Novel Chinese Medicine Formula for Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 162 participants.
Also called NCT06978023
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 162 participants
- Registry
-
NCT06978023
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Hong Kong SAR China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06978023. Randomized; quadruple masking; primary purpose treatment. Start 2025-05 (anticipated); primary completion 2026-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Novel Chinese Medicine Formula for Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Combination product)
- JM-LD
- Intervention (Combination product)
- JM-HD
- Intervention (Combination product)
- Placebo
- Lead sponsor
- Chinese University of Hong Kong
Record details
- Record id
cardio:ct-nct06978023- Content hash
ccf7b0581880ea34b9e868b9b4fba4442b5748ad29b01d041c4df6366cc3c4a4